[Results of the clinical study of a preparation of diiodobenzotef in malignant tumors].
作者信息
Karev N I, Garin A M, Blokhina N G, Pershin M P, Trapeznikova M F
出版信息
Klin Med (Mosk). 1975 May;52(5):50-3.
PMID:1133992
Abstract
摘要
相似文献
1
[Results of the clinical study of a preparation of diiodobenzotef in malignant tumors].[二碘苯替芬制剂在恶性肿瘤中的临床研究结果]
Klin Med (Mosk). 1975 May;52(5):50-3.
2
Phase II clinical trial of diaziquone in bronchogenic carcinoma.
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):921-2.
3
Phase II study of diaziquone in patients with advanced carcinoma of the lung.重氮醌用于晚期肺癌患者的II期研究。
Cancer Treat Rep. 1984 Sep;68(9):1193-4.
4
Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.氮丙啶基苯醌（AZQ）用于晚期乳腺癌：癌症与白血病B组II期试验
Cancer Treat Rep. 1982 Oct;66(10):1875-6.
5
Phase II clinical evaluation of AZQ in metastatic breast cancer.
Am J Clin Oncol. 1983 Feb;6(1):31-3.
6
[Complex treatment of bladder cancer with pre- and postoperative chemotherapy].[膀胱癌术前及术后化疗的综合治疗]
Urol Nefrol (Mosk). 1987 Jan-Feb(1):26-8.
7
Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.重氮醌用于晚期软组织和骨肉瘤的II期研究：一项西南肿瘤协作组的研究
Cancer Treat Rep. 1985 Sep;69(9):1035-6.
8
9
Phase II evaluation of diaziquone in recurrent head and neck cancer.
Cancer Treat Rep. 1986 May;70(5):671-2.
10
[Biological effects of leakadin].
Vopr Onkol. 1988;34(2):192-6.
Zotero 插件